News Focus
News Focus
Followers 85
Posts 12812
Boards Moderated 0
Alias Born 07/25/2008

Re: None

Saturday, 03/08/2014 9:17:38 AM

Saturday, March 08, 2014 9:17:38 AM

Post# of 80490
If Ariad can amass a $600 million investment for a non approved compound called Rida, imagine what the total investment they could receive for Ponatinib, an APPROVED compound on two continents!

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now